Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Medtronic
Merck

Last Updated: May 17, 2022

Investigational Drug Information for Isoquinoline


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Isoquinoline?

Isoquinoline is an investigational drug.

There have been 13 clinical trials for Isoquinoline. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2021.

The most common disease conditions in clinical trials are Cysticercosis, HIV Infections, and Taeniasis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), Jun Tao, and Centers for Disease Control and Prevention.

There are six hundred and five US patents protecting this investigational drug and forty-one international patents.

Recent Clinical Trials for Isoquinoline
TitleSponsorPhase
Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia PatientsTianjin Anding HospitalPhase 4
Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With HypertensionJun TaoPhase 4
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary InterventionPeking Union Medical College HospitalPhase 4

See all Isoquinoline clinical trials

Clinical Trial Summary for Isoquinoline

Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline

See all Isoquinoline clinical trials

US Patents for Isoquinoline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isoquinoline See Plans and Pricing Quinazolinone and isoquinolinone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (Tokyo, JP) See Plans and Pricing
Isoquinoline See Plans and Pricing Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid L'OREAL (Paris, FR) See Plans and Pricing
Isoquinoline See Plans and Pricing Methods and compositions for inhibition of Ras ARAXES PHARMA LLC (San Diego, CA) See Plans and Pricing
Isoquinoline See Plans and Pricing Humanized anti-Tn-MUC1 antibodies and their conjugates ADC Therpeutics S.A. (Epalinges, CH) Medimmune Limited (Cambridge, GB) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Isoquinoline

Drugname Country Document Number Estimated Expiration Related US Patent
Isoquinoline China CN105916963 2034-01-17 See Plans and Pricing
Isoquinoline European Patent Office EP3094703 2034-01-17 See Plans and Pricing
Isoquinoline Japan JP2017508728 2034-01-17 See Plans and Pricing
Isoquinoline South Korea KR20160103144 2034-01-17 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.